Key Record Dates
ClinicalTrials.gov Identifier: | NCT04335136 |
---|---|
Brief Title: | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (APN01-COVID-19) |
First Submitted : | April 1, 2020 |
First Submitted that Met QC Criteria : | April 3, 2020 |
First Posted : | April 6, 2020 |
Results First Submitted : | June 7, 2021 |
Results First Posted with QC Comments : | June 14, 2021 |
Results First Submitted that Met QC Criteria : | July 29, 2021 |
Results First Posted : | August 2, 2021 |
Last Update Submitted that Met QC Criteria : | July 29, 2021 |
Last Update Posted : | August 2, 2021 |